procainamide has been researched along with Mucocutaneous Lymph Node Syndrome in 1 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
Mucocutaneous Lymph Node Syndrome: An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zarazaga, G | 1 |
| Salazar, J | 1 |
| Oliván, MJ | 1 |
| García, MD | 1 |
| Felipe, J | 1 |
1 other study available for procainamide and Mucocutaneous Lymph Node Syndrome
| Article | Year |
|---|---|
[Kawasaki disease with coronary involvement].
Topics: Adrenal Cortex Hormones; Age Factors; Aneurysm; Child; Coronary Disease; Digitalis Glycosides; Human | 1983 |